L. Alexandrov, S. Nik-zainal, D. Wedge, S. Aparicio, S. Behjati et al., Signatures of mutational processes in human cancer, Nature, vol.27, issue.7463, pp.415-436, 2013.
DOI : 10.1093/bioinformatics/btr354

R. Amado, M. Wolf, M. Peeters, E. Van-cutsem, S. Siena et al., Is Required for Panitumumab Efficacy in Patients With Metastatic Colorectal Cancer, Journal of Clinical Oncology, vol.26, issue.10, pp.1626-1660, 2008.
DOI : 10.1200/JCO.2007.14.7116

C. Karapetis, S. Khambata-ford, D. Jonker, O. Callaghan, C. Tu et al., Mutations and Benefit from Cetuximab in Advanced Colorectal Cancer, New England Journal of Medicine, vol.359, issue.17, pp.1757-65, 2008.
DOI : 10.1056/NEJMoa0804385

G. Siravegna, B. Mussolin, M. Buscarino, G. Corti, A. Cassingena et al., Clonal evolution and resistance to EGFR blockade in the blood of colorectal cancer patients, Nature Medicine, vol.25, issue.7, pp.795-801, 2015.
DOI : 10.1093/bioinformatics/btp394

S. Kobayashi, T. Boggon, T. Dayaram, P. Jänne, O. Kocher et al., Mutation and Resistance of Non???Small-Cell Lung Cancer to Gefitinib, New England Journal of Medicine, vol.352, issue.8, pp.786-92, 2005.
DOI : 10.1056/NEJMoa044238

F. Bidard, J. Madic, P. Mariani, S. Piperno-neumann, A. Rampanou et al., Detection rate and prognostic value of circulating tumor cells and circulating tumor DNA in metastatic uveal melanoma, International Journal of Cancer, vol.91, issue.5, pp.1207-1220, 2014.
DOI : 10.1111/j.1755-3768.2012.02449.x

R. Lebofsky, C. Decraene, V. Bernard, M. Kamal, A. Blin et al., Circulating tumor DNA as a non-invasive substitute to metastasis biopsy for tumor genotyping and personalized medicine in a prospective trial across all tumor types, Molecular Oncology, vol.14, issue.4, pp.783-90, 2015.
DOI : 10.1093/bib/bbs017
URL : http://onlinelibrary.wiley.com/doi/10.1016/j.molonc.2014.12.003/pdf

B. Vogelstein, K. Kinzler, and P. Digital, Digital PCR, Proceedings of the National Academy of Sciences, vol.25, issue.4, pp.9236-9277, 1999.
DOI : 10.1126/science.2565047

I. Garcia-murillas, G. Schiavon, B. Weigelt, C. Ng, S. Hrebien et al., Mutation tracking in circulating tumor DNA predicts relapse in early breast cancer, Science Translational Medicine, vol.23, issue.302, pp.302-133, 2015.
DOI : 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4

F. Riva, F. Bidard, A. Houy, A. Saliou, J. Madic et al., Patient-Specific Circulating Tumor DNA Detection during Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer, Clinical Chemistry, vol.63, issue.3, pp.691-700, 2017.
DOI : 10.1373/clinchem.2016.262337

J. Douillard, G. Ostoros, M. Cobo, T. Ciuleanu, R. Cole et al., Gefitinib Treatment in EGFR Mutated Caucasian NSCLC: Circulating-Free Tumor DNA as a Surrogate for Determination of EGFR Status, Journal of Thoracic Oncology, vol.9, issue.9, pp.1345-53, 2014.
DOI : 10.1097/JTO.0000000000000263

E. Castellanos-rizaldos, C. Paweletz, C. Song, G. Oxnard, H. Mamon et al., Enhanced Ratio of Signals Enables Digital Mutation Scanning for Rare Allele Detection, The Journal of Molecular Diagnostics, vol.17, issue.3, pp.284-92, 2015.
DOI : 10.1016/j.jmoldx.2014.12.003
URL : https://doi.org/10.1016/j.jmoldx.2014.12.003

C. Karlovich, J. Goldman, J. Sun, E. Mann, L. Sequist et al., Assessment of EGFR Mutation Status in Matched Plasma and Tumor Tissue of NSCLC Patients from a Phase I Study of Rociletinib (CO-1686), Clinical Cancer Research, vol.22, issue.10, pp.2386-95, 2016.
DOI : 10.1158/1078-0432.CCR-15-1260

A. Vallée, L. Loupp, A. Denis, and M. , Efficiency of the Therascreen?? RGQ PCR kit for the detection of EGFR mutations in non-small cell lung carcinomas, Clinica Chimica Acta, vol.429, pp.8-11, 2014.
DOI : 10.1016/j.cca.2013.11.014

P. Sykes, S. Neoh, M. Brisco, E. Hughes, J. Condon et al., Quantitation of targets for PCR by use of limiting dilution, BioTechniques, vol.13, pp.444-453, 1992.

C. Hindson, J. Chevillet, H. Briggs, E. Gallichotte, I. Ruf et al., Absolute quantification by droplet digital PCR versus analog real-time PCR, Nature Methods, vol.15, issue.10, pp.1003-1008, 2013.
DOI : 10.1016/j.ymeth.2010.01.006
URL : http://europepmc.org/articles/pmc4118677?pdf=render

A. Whale, A. Devonshire, G. Karlin-neumann, J. Regan, J. L. Cowen et al., International Interlaboratory Digital PCR Study Demonstrating High Reproducibility for the Measurement of a Rare Sequence Variant, Analytical Chemistry, vol.89, issue.3, pp.1724-1757, 2017.
DOI : 10.1021/acs.analchem.6b03980

V. Taly, D. Pekin, L. Benhaim, S. Kotsopoulos, L. Corre et al., Multiplex Picodroplet Digital PCR to Detect KRAS Mutations in Circulating DNA from the Plasma of Colorectal Cancer Patients, Clinical Chemistry, vol.59, issue.12, pp.1722-1753, 2013.
DOI : 10.1373/clinchem.2013.206359

A. Pender, I. Garcia-murillas, R. S. Cutts, R. Kelly, G. Fenwick et al., Efficient Genotyping of KRAS mutant nonsmall cell lung cancer using a multiplexed droplet digital PCR approach, PLoS One, vol.10, pp.139074-139092, 2015.
DOI : 10.1371/journal.pone.0139074
URL : https://doi.org/10.1371/journal.pone.0139074

R. Bidshahri, D. Attali, K. Fakhfakh, K. Mcneil, A. Karsan et al., Quantitative Detection and Resolution of BRAF V600 Status in Colorectal Cancer Using Droplet Digital PCR and a Novel Wild-Type Negative Assay, The Journal of Molecular Diagnostics, vol.18, issue.2, pp.190-204, 2016.
DOI : 10.1016/j.jmoldx.2015.09.003

S. Findlay, K. Vincent, J. Berman, and L. Postovit, A Digital PCR-Based Method for Efficient and Highly Specific Screening of Genome Edited Cells, PLOS ONE, vol.407, issue.4, p.153901, 2016.
DOI : 10.1371/journal.pone.0153901.s002
URL : https://doi.org/10.1371/journal.pone.0153901

J. Madic, A. Kiialainen, F. Bidard, F. Birzele, G. Ramey et al., Circulating tumor DNA and circulating tumor cells in metastatic triple negative breast cancer patients, International Journal of Cancer, vol.16, issue.9, pp.2158-65, 2015.
DOI : 10.1186/s13058-014-0421-y
URL : http://onlinelibrary.wiley.com/doi/10.1002/ijc.29265/pdf

D. Attali, R. Bidshahri, C. Haynes, and J. Bryan, ddpcr: an R package and web application for analysis of droplet digital PCR data, F1000Research, vol.5, pp.1411-1412, 2016.
DOI : 10.12688/f1000research.9022.1
URL : https://f1000research.com/articles/5-1411/v1/pdf

S. Forbes, D. Beare, H. Boutselakis, S. Bamford, N. Bindal et al., COSMIC: somatic cancer genetics at high-resolution, Nucleic Acids Research, vol.166, issue.D1, pp.777-83, 2017.
DOI : 10.1016/j.cell.2016.06.017
URL : https://academic.oup.com/nar/article-pdf/45/D1/D777/8846917/gkw1121.pdf

F. Janku, H. Huang, T. Fujii, D. Shelton, K. Madwani et al., Multiplex KRASG12/G13 mutation testing of unamplified cell-free DNA from the plasma of patients with advanced cancers using droplet digital polymerase chain reaction, Ann Oncol, vol.28, pp.642-50, 2017.

E. Zonta, F. Garlan, N. Pé-cuchet, K. Perez-toralla, O. Caen et al., Multiplex Detection of Rare Mutations by Picoliter Droplet Based Digital PCR: Sensitivity and Specificity Considerations, PLOS ONE, vol.11, issue.13, pp.159094-159114, 2016.
DOI : 10.1371/journal.pone.0159094.s011
URL : http://doi.org/10.1371/journal.pone.0159094

C. Milbury, Q. Zhong, J. Lin, M. Williams, J. Olson et al., Determining lower limits of detection of digital PCR assays for cancer-related gene mutations, Biomolecular Detection and Quantification, vol.1, issue.1, pp.8-22, 2014.
DOI : 10.1016/j.bdq.2014.08.001

S. Sharma, D. Bell, J. Settleman, and D. Haber, Epidermal growth factor receptor mutations in lung cancer, Nature Reviews Cancer, vol.64, issue.3, pp.169-81, 2007.
DOI : 10.1016/S1525-7304(11)70394-1

M. Snyder, M. Kircher, A. Hill, R. Daza, and J. Shendure, Cell-free DNA Comprises an In??Vivo Nucleosome Footprint that Informs Its Tissues-Of-Origin, Cell, vol.164, issue.1-2, pp.57-68, 2016.
DOI : 10.1016/j.cell.2015.11.050
URL : https://doi.org/10.1016/j.cell.2015.11.050